Filter
366
Text search:
chlamydia
Featured
Recommendations
41
New Publications
111
Language
Document type
No document type
235
Guidelines
61
Studies & Reports
32
Manuals
14
Fact sheets
10
Strategic & Response Plan
6
Brochures
3
Infographics
3
Training Material
2
Countries / Regions
South Africa
14
Nepal
12
Global
12
India
11
Tanzania
10
Philippines
8
Rwanda
8
Germany
7
Western and Central Europe
7
Nigeria
6
Africa
6
Namibia
5
Ukraine
5
Congo, Democratic Republic of
4
Cameroon
4
Uganda
4
Zambia
4
Kenya
4
Indonesia
4
Ethiopia
3
Zimbabwe
3
Lesotho
3
Latin America and the Carribbean
3
Asia
3
Russia
3
Sierra Leone
2
Liberia
2
Senegal
2
Ghana
2
Bangladesh
2
Mozambique
2
Central African Republic
2
Argentina
2
Eswatini/ Swaziland
2
Brazil
2
Botswana
2
Paraguay
2
Eastern Europe
2
Togo
1
Pakistan
1
Syria
1
Cambodia
1
Malawi
1
Benin
1
Switzerland
1
Colombia
1
Madagascar
1
Myanmar / Burma
1
Chile
1
Yemen
1
Authors & Publishers
Publication Years
Category
Countries
128
Women & Child Health
42
Clinical Guidelines
41
Public Health
16
Capacity Building
8
Pharmacy & Technologies
5
Key Resources
4
Toolboxes
HIV
67
NTDs
22
Refugee
20
AMR
20
Pharmacy
12
TB
10
COVID-19
7
Rapid Response
6
Caregiver
6
Disability
5
Conflict
5
Mental Health
4
NCDs
4
Global Health Education
3
Planetary Health
2
Zika
1
Specific Hazards
1
This document updates the 2009 ECDC guidance on chlamydia control in Europe. It was developed by a technical expert group which conducted a critical review of the scientific evidence on the epidemiology of
...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (
...
Trachoma disease
Trachoma is a sequela following infection by the bacterium Chlamydia trachomatis (C. trachomatis). The disease is preventable, but still the cause of blindness in 1.9 million people world wide.
Accessed: 08.11.2020
Este documento ha sido concebido para proporcionar un marco que respalde los estudios de prevalencia de las ITS en los niveles local y nacional. El propósito de estos estudios es conocer la carga de las infecciones por NG y CT, dos ITS prioritarias que dan lugar a resultados obstétricos y perinata
...
Trachoma, caused by particular serovars of Chlamydia trachomatis, is the leading
infectious cause of blindness. Infection is transmitted within ocular and nasal secretions that are passed from person to person on fingers, fomites (such as clothing)
...
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for
...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without
...
Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings
Integrated Management of pregnancy and childbirth
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each formerly endemic EU. Usi
...
Trachoma is one of the 17 WHO-defined Neglected Tropical Diseases
(NTDs) that affect over 1 billion of the world’s poorest and most
marginalized people. It is caused by the bacterium chlamydia trachomatis.
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass drug administra
...
The Fifty-first World Health Assembly adopted resolution WHA51.11 in 1998, which targets the
global elimination of trachoma as a public health problem by 2020 (1). The strategy recommended
to achieve that goal is encapsulated by the acronym “SAFE”, which represents: Surgery for
individuals wi
...
